Merck's Molnupiravir: Second COVID Pill Is Second-Line, But Timing Helps Both Sponsor And US FDA :: Pink Sheet
Merck to share license for COVID-19 pill with other drugmakers to expand access
Merck signs deal to supply Singapore with its Covid-19 antiviral pill
Merck's Covid-19 Pill Heavily Used So Far Despite Concerns - WSJ
Legavrio COVID-19 Pill by Merck Continues Its Slump | Fierce Pharma
Pfizer COVID pill approved in Japan, following Merck treatment - Nikkei Asia
Merck (MRK) Molnupiravir Pill Could Change the Fight Against Covid - Bloomberg
Canada enters deals to procure Merck and Pfizer's Covid-19 antiviral pills
Merck Says Its Covid Pill Is Less Effective in a Final Analysis - The New York Times
Merck Issues Voluntary Nationwide Recall of CUBICIN® (daptomycin for injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles - Merck.com
Merck v Pfizer: here's how the two new COVID antiviral drugs work and will be used
Merck | Home
Merck says it's working to reduce levels of cancer-causing compound in popular diabetes drugs | CNN
Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut - WSJ
Explainer: How does Merck's COVID-19 pill compare to Pfizer's? | Reuters
Japan seeking supply of Merck's oral COVID-19 drug this year | The Asahi Shimbun: Breaking News, Japan News and Analysis
With UK nod, Merck drug becomes world's 1st pill for Covid treatment - The Economic Times
Could a popular COVID-19 antiviral supercharge the pandemic? | Science | AAAS
Merck has found source of Januvia contamination: report
FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited